Multiple Sclerosis: Diagnostic Methods

Multiple Sclerosis (MS) is a demyelinating autoimmune disease of the CNS, resulting in symptoms including optic neuritis and motor weakness. Here is the latest research on development and application of methods for diagnosis of MS.

August 8, 2020

Audiovestibular symptoms in patients with multiple sclerosis: A correlation between self-reported symptomatology and MRI findings to monitor disease progression

Multiple Sclerosis and Related Disorders
Arianna Di StadioEvanthia Bernitsas
August 6, 2020
Case Report
Open Access

Spinal meningioma in a patient with multiple sclerosis

Surgical Neurology International
Sricharan GopakumarJacob Mandel
August 9, 2020

Cardiovascular Imaging of Biology and Emotion: Considerations Toward a New Paradigm

Circulation. Cardiovascular Imaging
Judith L MeadowsRobert Soufer
August 4, 2020
Open Access

Imaging correlates of visual function in multiple sclerosis

PloS One
Eduardo CaverzasiAri J Green
August 6, 2020

Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption

Journal of Neurology
Kira AshtonM G Dwyer
August 9, 2020

Manganese-Enhanced MRI in Patients with Multiple Sclerosis

AJNR. American Journal of Neuroradiology
D J SutoD S Reich
August 8, 2020
Open Access

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis

Frontiers in Neurology
Katariina HänninenMerja Soilu-Hänninen
August 7, 2020

Ofatumumab versus Teriflunomide in Multiple Sclerosis

The New England Journal of Medicine
Stephen L HauserASCLEPIOS I and ASCLEPIOS II Trial Groups
August 12, 2020

Fatigue in multiple sclerosis patients with different clinical phenotypes: a clinical and mri study

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Olga MarchesiMaria A Rocca
July 29, 2020
Review

Cerebrospinal Fluid Testing for Multiple Sclerosis

Clinics in Laboratory Medicine
Joshua F Goldsmith, A Zara Herskovits
August 5, 2020

Switching to ocrelizumab in RRMS patients at risk of PML previously treated with extended interval dosing of natalizumab

Multiple Sclerosis : Clinical and Laboratory Research
Chiara Rosa MancinelliRuggero Capra
July 28, 2020

Investigation of the "central vein sign" in infratentorial multiple sclerosis lesions

Multiple Sclerosis and Related Disorders
Claudia E WeberPhilipp Eisele
August 4, 2020
Case Report

Biotinidase deficiency presenting as Neuromyelitis Optica Spectrum Disorder

Brain & Development
Snehal ShahLakshmi Nagarajan
August 6, 2020
Case Report

Facial pain as an initial manifestation of intramedullary cervical spinal cord tumor: A case report and literature review

Surgical Neurology International
Vidzhai DzhafarovEugenia Voronina

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis-diagnostic-methods/acd96ca1-6c8c-4a48-bd83-836a691b6c98